Reported Earlier: Smartkem Hires Anthony Amato And BAIPC To Support Strategic Growth Initiatives

Benzinga · 09/02/2025 16:29

Smartkem (NASDAQ:SMTK), which is seeking to change the world of electronics with a new class of transistor technology, today announced that it has engaged Anthony Amato and his firm, Bridge Associates International Pharmaceutical Consulting (BAIPC), to support specific strategic initiatives in support of the Company's long-term growth initiatives.

Mr. Amato brings extensive executive and consulting experience in the life sciences and technology sectors. He is the founder and principal of BAIPC, which provides strategic advisory services in corporate governance, compliance, and business development. He previously served as the Chief Executive Officer of BioSig Technologies, Inc. (BSGM), a Nasdaq listed company, which recently completed a successful transaction with Streamex Exchange Corporation. Mr. Amato still serves on the Board of Directors of BSGM.



Through BAIPC, Mr. Amato will provide advice and guidance on a non-exclusive basis to Smartkem's leadership team on evaluating and executing certain strategic opportunities and industry partnerships.